Form D · Other Health Care

Medicus Pharma Ltd.

Toronto, A6 · CIK 0001997296

Offering snapshot reported Jul 8, 2024 · SEC filing

Reported sold: $11M
Investors reported: 23
Minimum accepted: $25K
First sale: May 3, 2024

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$5,172,500 → $11,017,500

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Jul 8, 2024	Amendment	$11,017,500	$5,845,000vs Jun 18, 2024	23	SEC filing
Jun 18, 2024	Initial	$5,172,500	No comparison	23	SEC filing
Oct 13, 2023	Initial	$4,926,950	No comparison	68	SEC filing

Offering details

Securities: Equity, Debt, Option to acquire
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $375K
Form D file number: 021-516352

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
Togo PHL Management LLC	None

Source: Form D, filed Jul 8, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
William L. Ashton	Director
Raza Bokhari	Director, Executive
Carolyn Bonner	Executive
Edward Brennan	Executive
Robert J. Ciaruffoli	Director
Barry J. Fishman	Director
Larry Kaiser	Director
Frank Lavelle	Director
Sara R. May	Director
Erica Monaco	Executive
James Quinlan	Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:

100 King Street West Suite 3400
Toronto, A6, M5X 1A4